PTN


Roth Capital Reviews Palatin Technologies, Inc. Earnings

In a research report issued yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN), with a …

Canaccord Offers Commentary on Palatin Technologies, Inc. (PTN) Following Return of Bremelanotide EU Rights from Richter

In a research report released Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) with a $6 price …

Canaccord Reiterates Buy on Palatin Technologies, Inc. (PTN) Following Sprout Buyout Offer

In a research report released today, Canaccord analyst John Newman reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) with a $6 …

Palatin Technologies, Inc. Bullish Stance Solidified at Roth Capital Following Sprout’s Addyi Approval

In a research report published Wednesday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) with a …

Canaccord Raises Price Target for Palatin Technologies, Inc. on Back of FDA AdCom Recommendation to Approve Flibanserin

Ahead of the bell, Palatin Technologies, Inc. (NYSEMKT:PTN) shares have popped 51%, following today’s news that the FDA advisory committee voted 18-6 in …

Roth Capital Reiterates Buy On Palatin Tech Following FY2014 Update

In a research note released yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Palatin Tech. (NYSE:PTN) with a $6 price …

Roth Capital Reiterates Buy On Palatin Tech Following Novartis’s Presentation On PL-3994 and Natriuretic Peptides

In a research note published today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Palatin Technologies (NYSE: PTN) with a $6 …

Roth Capital Reiterates Buy On Palatin Technologies, Keeps $6 Price Target

In a research note released today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Palatin Technologies Inc. (PTN) and a price target of $6.

Palatin Technologies Reiterated With A Buy At Roth Capital

In a research note issued this morning, Roth Capital reiterated coverage with a “Buy” rating on Palatin Technologies, Inc. (PTN) and a price target of $6.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts